Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)

NCT02475720 · clinicaltrials.gov ↗
COMPLETED
Status
2000
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca